Close

Price Negotiations For 10 US Prescription Drugs To Be Shared

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Stem Cell Therapy Works for the Individual

Stem cell therapy has emerged as one of the...

Tjoapack Expands Injectable Packaging Capabilities Globally

Increased Capabilities in the United States Tjoapack is finishing up...

Biopharma Production with AI: A New Era in Manufacturing

A New Era of Biopharma Production with AI The biopharma...

A senior Biden White House official said on January 11 that the U.S. administration will provide a list of the ten prescription pharmaceuticals for which it intends to negotiate prices on September 1 and the costs a year later.

The Inflation Prevention Act, which was signed into law by President Joe Biden in August, among its features for the first time permits the federal Medicare healthcare program for those who are 65 older than age and the disabled to haggle pricing on some of the most powerful drugs.

The detailed timetable for the first year of discussions was released on January 11 by the U.S. Department of Health and Human Services (HHS) as well as the Centers for Medicare & Medicaid Services (CMS), which is in charge of managing Medicare and the negotiating process.

It had previously stated that it would disclose the 10 high-cost brand-name Part D medications that would be subject to price discussions in the autumn of 2023.

According to CMS Administrator Chiquita Brooks-LaSure, the agency plans to publish the agreed-upon maximum fair price in September 2024, taking effect in 2026.

Latest stories

Related stories

How Stem Cell Therapy Works for the Individual

Stem cell therapy has emerged as one of the...

Tjoapack Expands Injectable Packaging Capabilities Globally

Increased Capabilities in the United States Tjoapack is finishing up...

Biopharma Production with AI: A New Era in Manufacturing

A New Era of Biopharma Production with AI The biopharma...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back